Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Obesity
Pharma
Trump bought stock in drugmaker as admin boosted its obesity drugs
President Donald Trump earlier this year bought as much as $680,000 in stock of Eli Lilly, the maker of blockbuster obesity drugs.
Darius Tahir, KFF Health News
May 19, 2026 8:47am
Eli Lilly delivers $50M boost to UNICEF’s pediatric health push
May 14, 2026 11:33am
Novo, Lilly unveil new obesity data as GLP-1 rivalry grows
May 13, 2026 11:18am
Eli Lilly pauses Indian obesity awareness campaign: report
May 12, 2026 11:27am
Novo's Wegovy pill debuts with $355M in Q1
May 6, 2026 11:21am
French regulator fines Novo, Lilly over obesity drug promotion
May 6, 2026 9:40am
